Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab

Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer

(2009) C. Ferrario et al.   ANNALS OF ONCOLOGY

Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but notHER2/neu-positive breast cancer

(2009) Kan Yonemori et al.   CANCER

Meningeal carcinomatosis in HER2-overexpressing breast cancers

(2009) F. C. Bidard et al.   JOURNAL OF NEURO-ONCOLOGY

High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer

(2008) O. Mir et al.   ANNALS OF ONCOLOGY

Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report

(2008) Hans-Joachim Stemmler et al.   ANTI-CANCER DRUGS

Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab

(2008) Mariantonietta Colozza et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY